Back to News
Market Impact: 0.22

2 Factors Dragging Down Axon Enterprise Stock: Should You Buy the Dip?

AXONKTOSNVDAINTCNFLX
Artificial IntelligenceCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst InsightsMarket Technicals & FlowsInvestor Sentiment & Positioning

Axon Enterprise shares have fallen about 30% this year amid lingering concerns over valuation and stock-based compensation, even as earlier AI-disruption fears have faded. The company reported an earnings beat and stronger guidance, but stock-based compensation totaled $610.1 million last year and is still expected to be $590 million to $620 million in 2026. The article argues investors may want to wait for a lower entry point given Axon's roughly 53x forward earnings multiple and near-term uncertainty.

Analysis

The market is treating AXON like a high-duration software multiple with defense-like end demand, which is exactly why the stock has become fragile: any hint of slower conversion from growth to earnings gets punished twice, once on sentiment and again on valuation. The key second-order issue is that heavy stock-based comp creates a hidden supply overhang; even if reported margins improve, equity dilution can suppress per-share compounding and keep forward multiple expansion capped. That means the stock’s near-term trading range is likely driven more by confidence in 2026–2027 EPS durability than by headline revenue growth. The interesting competitive angle is that AXON’s AI narrative cuts both ways. AI integration can deepen customer lock-in and raise switching costs, but it also raises investor expectations for software-like economics; if the company cannot show operating leverage faster than comp dilution, the market will continue to price it as a “nice story, expensive stock.” On the other side, KTOS is a useful relative-value read-through: if defense/tech names continue to command extreme multiples, AXON’s multiple can look less stretched in isolation, but that does not solve the absolute valuation problem if public-sector budgets tighten. The catalyst path is cleaner than the trend suggests: the next earnings print is the first real test of whether the post-rotation selloff was just factor-driven or a preview of a slower re-rating cycle. The overhang window is months, not days: any guide-down, softer bookings, or a reset in comp could trigger another leg lower, while a clean beat with stable 2026 guidance could force a squeeze. The contrarian view is that the market may be underestimating the scarcity value of a scaled mission-critical platform in public safety; if AI-enabled workflows become procurement standard, AXON could re-accelerate into a premium operating profile, but investors need proof, not promise.